Posts

PwC Appoints Jan Sijbrand and Troy Paredes

Jan Sijbrand and Troy Paredes will join the board of PwC, which is responsible for the governance of PwCIL and the PwC Network, oversight of PwC’s network leadership team, and approval of the standards by which each PwC firm must abide.

From 5 March 2021, Jan and Troy will work with the existing 18 board members who are made up of partners and principals from 13 PwC firms from across the world and as of June 24, 2021 they will formally join the new PwCIL board which is currently being elected.

Jan has enjoyed a long career in banking, including head of risk management for ABN Amro, Chief Risk Officer and member of the managing board of NIBC Bank, and member of the executive board and chairman for supervision of De Nederlandsche Bank.

In addition Jan was a member of the supervisory board of the European Central Bank from 2015 -2018 and a member of the board of supervisors of the European Banking Authority from 2011-2018. Jan brings a wealth of experience of financial services, risk management, oversight and supervision.

Jan also currently serves as deputy chairman of the supervisory board of PwC Netherlands.

Troy is the founder of Paredes Strategies LLC, a consulting firm. He served as an SEC commissioner in the United States from 2008 to 2013 – during the financial crisis and its aftermath.

During his time with the SEC, Troy played a key role in rulemakings and other regulatory matters concerning all aspects of securities regulation.

Troy brings to the PwCIL board a truly extensive breadth of experience, including governance, compliance, strategy and regulatory. Troy also currently serves as an external director on the oversight board of PwC United States.

Investigating Claims on Behalf of The Investors

The Schall Law Firm announces that it is investigating claims on the behalf of the investors in Alder BioPharmaceuticals, Inc. for potential breaches of fiduciary duty on the part of its directors in connection with the pending sale of the Company to H. Lundbeck A/S.

Alder is a biopharmaceutical company committed to transforming migraine treatment through the discovery, development and commercialisation of novel therapeutic antibodies. The company’s mission is to forever change migraine treatment and give people with migraine their lives back.

The Schall Law Firm represents investors injured by stock fraud, breaches of fiduciary duty, and other management and director malfeasance.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website, or by email at [email protected].

The Schall Law Firm represents investors on a contingency fee basis. We are a securities class action firm singularly committed to recovering shareholder money from publicly traded companies that committ fraud.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

The Schall Law Firm represents investors on a contingency fee basis. We are a securities class action firm singularly committed to recovering shareholder money from publicly traded companies that commit fraud.